VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,679 | -45.7% | 174,621 | -15.7% | 0.03% | -35.0% |
| Q2 2023 | $4,930 | +52.7% | 207,211 | +63.3% | 0.04% | +48.1% |
| Q1 2023 | $3,228 | -42.0% | 126,901 | -33.4% | 0.03% | -66.7% |
| Q4 2022 | $5,569 | -99.8% | 190,654 | +75.0% | 0.08% | +179.3% |
| Q3 2022 | $2,235,000 | +23.7% | 108,968 | +11.5% | 0.03% | +26.1% |
| Q1 2022 | $1,807,000 | +19.1% | 97,745 | +27.3% | 0.02% | +43.8% |
| Q4 2021 | $1,517,000 | – | 76,757 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |